Device Authority targets a more practical route into automotive cybersecurity spending

Tern plc

Device Authority is trying to make its Industry Proof of Value relevant at a point when automotive cybersecurity is becoming a more immediate operational issue for manufacturers and suppliers. The company’s argument is straightforward. PKI and key management are no longer just technical matters. As vehicle architectures become more software-defined and connected, and as regulatory requirements tighten, control over cryptographic processes is moving closer to the centre of how OEMs manage risk, compliance and production.

Device Authority is offering a defined way for OEMs and Tier 1 suppliers to test how secure device identity, certificate lifecycle management, key generation, storage, distribution and BYOK models would work in practice. The point of the PoV is to move discussions away from theory and into a measurable operating model without requiring a full deployment at the outset.

This makes the proposition easier to understand commercially. In markets where decision cycles are long and implementation risk is closely scrutinised, a structured proof environment can help customers test both technical fit and regulatory relevance before making a wider commitment. That is important because buyers in this area are not simply looking for another cybersecurity product. They are trying to establish whether they can show control, retain visibility and support production at scale under tighter compliance expectations.

Device Authority is also placing clear emphasis on regulatory alignment. The source says the PoV is designed to map technical outcomes to requirements such as cryptographic governance, certificate traceability, secure lifecycle controls, production auditability and rapid revocation and update capabilities.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Tern Plc announces 90% take-up of Open Offer

Tern Plc has received valid acceptances for 50.9 million Open Offer Shares, representing approximately 90% of the shares available. The fully underwritten offer will raise approximately £509,368 before expenses, with admission of the new shares expected on 24 September 2026.

Talking Medicines moves to capture pharma demand for better patient intelligence

Tighter US pharma advertising rules could increase demand for patient intelligence, supporting the relevance of Talking Medicines’ DrugVoice platform.

Tern portfolio company Talking Medicines launches ‘Intent to Prescribe’ DrugVoice application

Talking Medicines has launched a new DrugVoice application combining its Message Resonance Score™ with near-real-time point-of-care data to help pharmaceutical companies assess links between HCP message alignment and prescribing intent.

Device Authority targets secure digital infrastructure for smart ports

Device Authority's Smart, Green Port Blueprint shows how secure device management can support the wider rollout of connected infrastructure across modern ports.

Talking Medicines highlights strategic signals emerging across the GLP-1 consumer market

GLP-1 consumers are increasingly weighing access, affordability, quality, clinical oversight and treatment support, creating new strategic considerations across the wider life sciences market.

Tern Plc launches £509,368 underwritten Open Offer

Tern Plc has announced an underwritten Open Offer to raise approximately £509,368 through the issue of 56.6 million shares at 0.90p each. Qualifying shareholders may subscribe for one new share for every 16 shares held, with the offer closing on 22 September 2026.

Search